80
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2011
Study Completion Date
November 30, 2011
CA4P
CA4P 60mg/m squared for Days 1, 8, 15 for 6 cycles
paclitaxel
200mg/m squared on Day 1
carboplatin
6 AUC on Day 1 following paclitaxel
Specialized Hospital for Active Treatment of Oncology, Sofia
Lo Studio E la Cura, Milan
Sidney Kimmel Comprehensive Cancer Care Center at John Hopkins, Baltimore
West Virginia University, Morgantown
Winship Cancer Institute, Emory University, Atlanta
Istituto Oncologico Veneto (IOV) - IRCCS, Padua
Ireland Cancer Center/Division od Hematology, Cleveland
University of Minnesota Otolaryngology Department, Minneapolis
Azienda Ospedaliero - Universitaria Pisana, Pisa
Telaviv Sourasky Medical Center, Head and Neck Service Division of Oncology, Tel Aviv
University of Texas M.D. Anderson Cancer Center, Houston
University of Colorado Cancer Center, Aurora
USC/Norris Comprehensive Cancer Center, Los Angeles
Oregon Health and Science University, Portland
All India Institute of Medical Sciences, New Delhi
Apollo Cancer Institute, New Delhi
City Clinical Oncology Dispensary, Saint Petersburg
SC Meditech SRL, Craiova
Tata Memorial Centre, Mumbai
Institutul Oncologic, Cluj-Napoca
Ruby Hall Clinic, Pune
Mediciti Hospital, Hyderabaad
Clinical County Hospital Sibiu, Sibiu
Shirdi Sai Baba Cancer Hospital, Manipal
Centr of Medical Oncology, Iași
"Emergency Clinical County Hospital Sf. loan cel Nou", Suceava
Yale University, School of Medicine, New Haven
Belarus National Medical University, Minsk
Regional Oncology Dispensary with Inpatient Sector, Plodiv
Universtiy Multiprofile Hospital, ISUI, Clinic of Oncotherapy, Sofia
University Hospital, Cairo, Cairo
Kidwai Memorial Hospital, Bangalore
Christian Medial College, Vellore
INT Napoli Fondazione Pascale, Napoli
Regional Clinical Oncology Dispensary, Lviv
Southampton Hospital Oncology Centre, Southampton
Zaklad Medyczny Nuklearnej i Endykrynologii, Gliwice
Klinika Nowotworow Glowy i Szyji, Warsaw
Ukrainian Academy of Medical Science, Lomonosova 33/43
Beatson Oncology Centre, Gartnavel General Hospital, Glasgow
Royal Marsden Hospital and Institute of Cancer Research, London
Lead Sponsor
Mateon Therapeutics
INDUSTRY